We are live on ! Find out more
MAM

Morse Asset Management Portfolio holdings

AUM $481M
1-Year Est. Return 46%
This Fund
S&P 500
This Quarter Est. Return
-14.93%
1 Year Est. Return
+46%
3 Year Est. Return
+152.98%
5 Year Est. Return
+238.35%
10 Year Est. Return
AUM
$282M
AUM Growth
-$97.8M
Cap. Flow
-$39.3M
Cap. Flow %
-13.96%
Top 10 Hldgs %
36.55%
Holding
145
New
10
Increased
27
Reduced
61
Closed
26

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$2.29M
2
VZ icon
Verizon
VZ
+$1.75M
3
FTNT icon
Fortinet
FTNT
+$1.64M
4
DIS icon
Walt Disney
DIS
+$1.54M
5
CRM icon
Salesforce
CRM
+$1.52M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.8%
2 Technology 19.41%
3 Industrials 16.55%
4 Healthcare 15.03%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$208B
$3.46M 1.23%
15,479
+2,905
+23% +$682K
AXP icon
27
American Express
AXP
$226B
$3.31M 1.18%
34,710
+2,840
+9% +$297K
MMM icon
28
3M
MMM
$91.9B
$3.27M 1.16%
20,535
-1,256
-6% -$208K
LVS icon
29
Las Vegas Sands
LVS
$31.6B
$3.17M 1.12%
60,845
+4,015
+7% +$218K
GILD icon
30
Gilead Sciences
GILD
$162B
$2.98M 1.06%
47,625
-1,860
-4% -$130K
MPC icon
31
Marathon Petroleum
MPC
$91.2B
$2.88M 1.02%
48,850
+3,575
+8% +$244K
MDB icon
32
MongoDB
MDB
$24.9B
$2.74M 0.97%
32,690
+5,235
+19% +$403K
CAT icon
33
Caterpillar
CAT
$402B
$2.65M 0.94%
20,865
-75
-0.4% -$9.76K
ZTS icon
34
Zoetis
ZTS
$32.2B
$2.62M 0.93%
30,625
+6,525
+27% +$588K
ABBV icon
35
AbbVie
ABBV
$454B
$2.53M 0.9%
27,485
-2,680
-9% -$236K
CELG
36
DELISTED
Celgene Corp
CELG
$2.46M 0.87%
38,440
-100
-0.3% -$7.38K
EXPD icon
37
Expeditors International
EXPD
$22.4B
$2.41M 0.85%
35,350
-200
-0.6% -$14K
FDX icon
38
FedEx
FDX
$73.5B
$2.35M 0.84%
14,593
-7,170
-33% -$1.52M
ALK icon
39
Alaska Air
ALK
$5.3B
$2.18M 0.78%
35,875
+3,765
+12% +$243K
MRK icon
40
Merck
MRK
$323B
$2.14M 0.76%
29,319
EVR icon
41
Evercore
EVR
$13.2B
$2.13M 0.76%
29,830
-200
-0.7% -$16.4K
DAL icon
42
Delta Air Lines
DAL
$57B
$2.1M 0.74%
+42,000
New +$2.29M
LLL
43
DELISTED
L3 Technologies, Inc.
LLL
$2.09M 0.74%
12,040
-750
-6% -$144K
HQY icon
44
HealthEquity
HQY
$8.28B
$2.05M 0.73%
34,325
-2,445
-7% -$197K
NKE icon
45
Nike
NKE
$62.5B
$1.94M 0.69%
26,100
+700
+3% +$52.4K
XOM icon
46
ExxonMobil
XOM
$642B
$1.91M 0.68%
27,994
FSTX
47
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.75M 0.62%
42,175
-5,338
-11% -$240K
EBS icon
48
Emergent Biosolutions
EBS
$378M
$1.6M 0.57%
27,050
+2,950
+12% +$190K
CVX icon
49
Chevron
CVX
$378B
$1.6M 0.57%
14,739
+169
+1% +$19.6K
EL icon
50
Estee Lauder
EL
$30.1B
$1.59M 0.56%
12,200
-1,000
-8% -$136K

Similar funds

Morse Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Morse Asset Management held 145 positions worth $282M, down 26% from $379M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Morse Asset Management withdrew a net $39.3M in Q4 2018, closing 26 positions and reducing 61 holdings. Its most notable exit was Idexx Laboratories, an estimated $4.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Morse Asset Management opened a new position in Delta Air Lines worth $2.1M.

  • Morse Asset Management's largest Q4 2018 buy was Delta Air Lines: 42,000 shares worth $2.1M.
  • Morse Asset Management added most to Verizon in Q4 2018, an estimated $1.75M increase.
  • Morse Asset Management's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $4.78M.
  • Morse Asset Management fully exited Idexx Laboratories in Q4 2018, selling an estimated $4.5M.
  • Morse Asset Management's ten largest holdings make up 37% of its $282M portfolio in Q4 2018.
  • Morse Asset Management opened 10 new positions and closed 26 in Q4 2018.
  • Morse Asset Management's portfolio value fell 26% quarter-over-quarter to $282M.

Based on Morse Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.